Iambic Therapeutics is a clinical-stage life science and technology company that develops novel medicines using its AI-driven discovery and development platform. Founded in 2019, the company integrates artificial intelligence with physics principles to tackle complex molecular design challenges, aiming to accelerate drug discovery timelines and reduce development risks for pharmaceutical and biotech organizations.